摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(S)-1-(2,2-Dimethyl-propionyl)-pyrrolidin-2-ylmethyl]-((S)-1-isopropylcarbamoyl-ethyl)-carbamic acid benzyl ester | 214046-98-7

中文名称
——
中文别名
——
英文名称
[(S)-1-(2,2-Dimethyl-propionyl)-pyrrolidin-2-ylmethyl]-((S)-1-isopropylcarbamoyl-ethyl)-carbamic acid benzyl ester
英文别名
——
[(S)-1-(2,2-Dimethyl-propionyl)-pyrrolidin-2-ylmethyl]-((S)-1-isopropylcarbamoyl-ethyl)-carbamic acid benzyl ester化学式
CAS
214046-98-7
化学式
C24H37N3O4
mdl
——
分子量
431.575
InChiKey
IDBQDKQJKWPTOE-ICSRJNTNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.58
  • 重原子数:
    31.0
  • 可旋转键数:
    7.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    78.95
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    [(S)-1-(2,2-Dimethyl-propionyl)-pyrrolidin-2-ylmethyl]-((S)-1-isopropylcarbamoyl-ethyl)-carbamic acid benzyl ester 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 生成 (2S)-2-[[(2S)-1-(2,2-dimethylpropanoyl)pyrrolidin-2-yl]methylamino]-N-propan-2-ylpropanamide
    参考文献:
    名称:
    The non protonable reduced aza-peptide fragment
    摘要:
    The reduced aza-peptide fragment (C-alpha-CH2-NH-N(alpha)R-CO-NH-C-alpha) is obtained by reduction of the semicarbazone moiety (C-alpha-CH=N-N(alpha)R-CO-NH-C-alpha) in an imino aza-peptide. It differs from the aminomethylene link (C-alpha-CH2-NH-C(alpha)HR-CO-NH-C-alpha) found in the reduced peptides by the absence of protonation in water in the 2-12 pH range. The reduced aza-analogue of the Pro-Ala dipeptide has been studied in solution by H-1-NMR and IR spectroscopy, and in the solid state by X-ray diffraction. Its structure is quite similar to that of the neutral reduced dipeptide analogue in solution. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0040-4039(97)00410-3
  • 作为产物:
    参考文献:
    名称:
    The non protonable reduced aza-peptide fragment
    摘要:
    The reduced aza-peptide fragment (C-alpha-CH2-NH-N(alpha)R-CO-NH-C-alpha) is obtained by reduction of the semicarbazone moiety (C-alpha-CH=N-N(alpha)R-CO-NH-C-alpha) in an imino aza-peptide. It differs from the aminomethylene link (C-alpha-CH2-NH-C(alpha)HR-CO-NH-C-alpha) found in the reduced peptides by the absence of protonation in water in the 2-12 pH range. The reduced aza-analogue of the Pro-Ala dipeptide has been studied in solution by H-1-NMR and IR spectroscopy, and in the solid state by X-ray diffraction. Its structure is quite similar to that of the neutral reduced dipeptide analogue in solution. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0040-4039(97)00410-3
点击查看最新优质反应信息

文献信息

  • Structural Comparison of Homologous Reduced Peptide, Reduced Azapeptide, Iminoazapeptide, and Methyleneoxypeptide Analogues
    作者:R. Vanderesse、V. Grand、D. Limal、A. Vicherat、M. Marraud、C. Didierjean、A. Aubry
    DOI:10.1021/ja980937o
    日期:1998.9.1
    The homologous RCO-Pro-Xaa-NHR' model pseudodipeptides containing the reduced peptide ((CCH2NHCalpha)-C-alpha), reduced azapeptide ((CCH2NHNalpha)-C-alpha), methyleneoxy ((CCH2OCalpha)-C-alpha), and iminoazapeptide ((CCH)-C-alpha=NNalpha) surrogate of the middle amide group have been prepared. Their structural analysis has been carried out in solution by H-1 NMR and IR spectroscopy and in the solid state by X-ray diffraction. The last three fragments, not protonated in the pH range 2-12, and the reduced fragment in its neutral amine form induce quite similar molecular structures characterized by a hydrogen bond between NHR' and the N/O atom replacing the amide NH group and closing a five-membered cycle. The neutral amine or protonated ammonium state of the reduced amide fragment, with a pK(a) value of about 7, depends on the environment. Protonation induces a conformational transition due to the strong proton donating properties of the ammonium group which interacts with the RCO carbonyl.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸